Prof. Alan Lyles is principal author of a journal article from a symposium on global trends in the use of "biosimilars" - pharmaceuticals designed to have active properties similar to those of a drug that has previously been licensed.
Prof. Sascha Sheehan writes in The National Interest about the growing encroachment of crucial functions of daily life, and the need for government oversight.
Prof. Alan Lyles is principal author of a journal article from a symposium on global trends in the use of "biosimilars" - pharmaceuticals designed to have active properties similar to those of a drug that has previously been licensed.
Prof. Sascha Sheehan writes in The National Interest about the growing encroachment of crucial functions of daily life, and the need for government oversight.
